Emerging Trends in Understanding Chemotherapy-Induced Peripheral Neuropathy
- 1 September 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Pain and Headache Reports
- Vol. 17 (10), 1-9
- https://doi.org/10.1007/s11916-013-0364-5
Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) is a major concern in oncology practice given the increasing number of cancer survivors and the lack of effective treatment. The incidence of peripheral neuropathy depends upon the anticancer drug used, but is commonly under-reported in clinical trials. Several animal models have been developed in an attempt to better characterize the pathophysiological mechanisms underlying these CIPN and to find more specific treatments. Over the past two decades, three main trends have emerged from preclinical research on CIPN. There is a compelling body of evidence that neurotoxic anticancer drugs affect the peripheral sensory nerve by directly targeting the mitochondria and producing oxidative stress, by functionally impairing the ion channels and/or by triggering immunological mechanisms through the activation of satellite glial cells. These various neurotoxic events may account for the lack of effective treatment, as neuroprotection may probably only be achieved using a polytherapy that targets all of these mechanisms. The aim of this review is to describe the clinical features of CIPN and to summarize the recent trends in understanding its pathophysiology.Keywords
This publication has 102 references indexed in Scilit:
- Healthcare Costs and Workloss Burden of Patients with Chemotherapy-Associated Peripheral Neuropathy in Breast, Ovarian, Head and Neck, and Nonsmall Cell Lung CancerChemotherapy Research and Practice, 2012
- Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathyExperimental Neurology, 2011
- Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the ratNeuroscience, 2011
- Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patientsSupportive Care in Cancer, 2011
- Prolonged Oxaliplatin Exposure Alters Intracellular Calcium Signaling: A New Mechanism to Explain Oxaliplatin-Associated Peripheral NeuropathyClinical Colorectal Cancer, 2011
- Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neuronsNeurobiology of Disease, 2011
- Oxaliplatin‐induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptorsEMBO Molecular Medicine, 2011
- Differential Expression of ATP7A, ATP7B and CTR1 in Adult Rat Dorsal Root Ganglion TissueMolecular Pain, 2010
- Oxaliplatin neurotoxicity – no general ion channel surface-charge effectJournal of Negative Results in BioMedicine, 2009
- Paclitaxel- and vincristine-evoked painful peripheral neuropathies: Loss of epidermal innervation and activation of Langerhans cellsExperimental Neurology, 2006